Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,318.00 0.00 (0.00%)

Bid:

13,100.00

Ask:

15,000.00

Spread: 1,900.00 (14.504%)

Market Cap: £222.05b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

AstraZeneca receives EU approval for Tagrisso lung cancer treatment

(Alliance News) - AstraZeneca PLC on Monday said it has received approval in the European Union for Tagrisso, its non-small cell lung cancer treatment...

LONDON BRIEFING: Lower call as Brits fear "January spending squeeze"

(Alliance News) - Stocks in London were called to open down on Monday morning, as investors digest some unwelcome UK economic news at the start of a h...

AstraZeneca lung cancer drug Tagrisso approved by EU regulators

(Sharecast News) - AstraZeneca's lung cancer treatment Tagrisso has been approved by European Union regulators on the back of "powerful results" from ...

PRESS: AstraZeneca sees sales slump in China after arrest of exec - FT

(Alliance News) - Sales in China have suffered for AstraZeneca PLC after the arrest of its country president, the Financial Times reported on Wednesda...

LONDON MARKET OPEN: Stocks red as French credit rating gets downgrade

(Alliance News) - Stock prices in London opened mostly lower on Monday, following another disappointing data release from China.

IN BRIEF: Hutchmed to get Takeda milestone payment

Hutchmed (China) Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pharmaceutical Co ...

IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results

Merck & Co Inc and AstraZeneca PLC - Rahway, New Jersey and Cambridge, England-based pharmaceutical firms - Report positive long-term results from pha...

AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday announced they have been granted a breakthrough therapy designation in the US to...